Erytech Pharma SA (DE:2E4A)
FRANKFURT:2E4A

Erytech Pharma SA (DE:2E4A) Stock Price & Analysis

0 Followers

2E4A Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€0.19 - €1.68
Previous Close€0.71
Volume0.00
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)N/A
Beta2.05
Next EarningsMar 13, 2023
EPS Estimate-€0.17
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)N/A
Shares Outstanding31,016,053
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Price to Book (P/B)0.81
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
AlphaN/A
Number of Analyst Covering0


Financials

Annual

2E4A FAQ

What was Erytech Pharma SA’s price range in the past 12 months?
Erytech Pharma SA lowest stock price was €0.19 and its highest was €1.68 in the past 12 months.
    What is Erytech Pharma SA’s market cap?
    Currently, no data Available
    When is Erytech Pharma SA’s upcoming earnings report date?
    Erytech Pharma SA’s upcoming earnings report date is Mar 13, 2023 which is in 34 days.
      How were Erytech Pharma SA’s earnings last quarter?
      Erytech Pharma SA released its earnings results on Nov 21, 2022. The company reported -€0.163 earnings per share for the quarter, beating the consensus estimate of -€0.329 by €0.166.
        Is Erytech Pharma SA overvalued?
        According to Wall Street analysts Erytech Pharma SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Erytech Pharma SA pay dividends?
          Erytech Pharma SA does not currently pay dividends.
          What is Erytech Pharma SA’s EPS estimate?
          Erytech Pharma SA’s EPS estimate is -€0.17.
            How many shares outstanding does Erytech Pharma SA have?
            Currently, no data Available
            What happened to Erytech Pharma SA’s price movement after its last earnings report?
            Erytech Pharma SA reported an EPS of -€0.163 in its last earnings report, beating expectations of -€0.329. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Erytech Pharma SA?
              Currently, no hedge funds are holding shares in DE:2E4A

              ---

              Erytech Pharma SA Stock Smart Score

              1
              Underperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -39.15%
              12-Months-Change

              Fundamentals

              Return on Equity
              -93.47%
              Trailing 12-Months
              Asset Growth
              -30.59%
              Trailing 12-Months
              The Erytech Pharma SA Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Erytech Pharma SA

              ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. It engages in developing and producing therapeutic products for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              scPharmaceuticals
              Evelo Biosciences
              Nucana
              Rhythm Pharmaceuticals

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis